Standard Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-725,674
Closed -$20.4M 16
2016
Q1
$20.4M Hold
725,674
2.04% 12
2015
Q4
$22.2M Hold
725,674
1.55% 15
2015
Q3
$21.6M Buy
725,674
+520,887
+254% +$16.7M 1.53% 15
2015
Q2
$6.51M Buy
204,787
+15,747
+8% +$513K 0.37% 36
2015
Q1
$6.24M Buy
+189,040
New +$6.01M 0.38% 25
2014
Q3
Sell
-128,061
Closed -$3.61M 200
2014
Q2
$3.61M Buy
128,061
+41,154
+47% +$1.17M 0.23% 50
2014
Q1
$2.65M Buy
86,907
+1,862
+2% +$55.5K 0.25% 64
2013
Q4
$2.47M Buy
+85,045
New +$2.48M 0.18% 50

Other funds holding PFE

Standard Investments's PFE Position: Q2 2016 in Review

Standard Investments sold out of Pfizer (PFE) in Q2 2016, closing a stake of 725,674 shares — an estimated $20.4M sold.

Standard Investments first reported a position in PFE in Q4 2013 and held it in 8 quarters. The position peaked at $22.2M in Q4 2015. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Standard Investments reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Standard Investments sold 725,674 Pfizer shares in Q2 2016, an estimated $20.4M.
  • Standard Investments first reported a position in Pfizer in Q4 2013 and held it in 8 quarters.
  • Standard Investments's Pfizer position peaked at $22.2M in Q4 2015.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Standard Investments's 13F filing for Q2 2016, filed 15 Aug 2016.